This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Suman Dasgupta: Innovator in Pharmaceutical Composition for Lung Cancer Treatment
Introduction
Suman Dasgupta is an accomplished inventor based in Santiniketan, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of lung cancer. His innovative approach combines natural compounds to create effective therapeutic solutions.
Latest Patents
Dasgupta holds a patent for a synergistic pharmaceutical composition useful for the treatment of lung cancer. This invention comprises Compound C2 (Neo-isopulegol), C3 (Iso-pulegol), and C4 (Citronellol), which are derived from herbal seed extracts. The composition has shown promising activity in killing A549 lung cancer cells, either alone or in combination.
Career Highlights
Throughout his career, Suman Dasgupta has worked with notable organizations such as the Council of Scientific and Industrial Research and Visva-Bharati. His work has focused on developing innovative solutions that leverage natural compounds for medical applications.
Collaborations
Dasgupta has collaborated with esteemed colleagues, including Nabin Chandra Barua and Sandeep Mukherjee. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Suman Dasgupta's work exemplifies the intersection of innovation and healthcare, particularly in the fight against lung cancer. His contributions through patenting a synergistic pharmaceutical composition highlight the potential of natural compounds in medical treatments.